-
1
-
-
48249125791
-
Malignant gliomas in adults
-
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507.
-
(2008)
N Engl J Med.
, vol.359
, Issue.5
, pp. 492-507
-
-
Wen, P.Y.1
Kesari, S.2
-
2
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
-
(2005)
N Engl J Med.
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
-
3
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
-
(2009)
Lancet Oncol.
, vol.10
, Issue.5
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
4
-
-
84866147745
-
Current trends in targeted therapies for glioblastoma multiforme
-
Ohka F, Natsume A, Wakabayashi T. Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int. 2012;2012:878425.
-
(2012)
Neurol Res Int.
, vol.2012
-
-
Ohka, F.1
Natsume, A.2
Wakabayashi, T.3
-
5
-
-
79952740612
-
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
-
Keunen O, Johansson M, Oudin A, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A. 2011;108(9):3749-3754.
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, Issue.9
, pp. 3749-3754
-
-
Keunen, O.1
Johansson, M.2
Oudin, A.3
-
6
-
-
79955582712
-
Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
-
Uhm JH, Ballman KV, Wu W, et al. Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. Int J Radiat Oncol Biol Phys. 2011;80(2):347-353.
-
(2011)
Int J Radiat Oncol Biol Phys.
, vol.80
, Issue.2
, pp. 347-353
-
-
Uhm, J.H.1
Ballman, K.V.2
Wu, W.3
-
7
-
-
80052749324
-
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure
-
Lu-Emerson C, Norden AD, Drappatz J, et al. Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure. J Neurooncol. 2011;104(1):287-291.
-
(2011)
J Neurooncol.
, vol.104
, Issue.1
, pp. 287-291
-
-
Lu-Emerson, C.1
Norden, A.D.2
Drappatz, J.3
-
8
-
-
33947646898
-
Inhibiting kinases in malignant gliomas
-
Chi AS, Wen PY. Inhibiting kinases in malignant gliomas. Expert Opin Ther Targets. 2007;11(4):473-496.
-
(2007)
Expert Opin Ther Targets.
, vol.11
, Issue.4
, pp. 473-496
-
-
Chi, A.S.1
Wen, P.Y.2
-
9
-
-
67650999875
-
The basics of epithelial-mesenchymal transition
-
Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420-1428.
-
(2009)
J Clin Invest.
, vol.119
, Issue.6
, pp. 1420-1428
-
-
Kalluri, R.1
Weinberg, R.A.2
-
10
-
-
0346724511
-
Epithelial-mesenchymal transition and its implications for fibrosis
-
Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112(12):1776-1784.
-
(2003)
J Clin Invest.
, vol.112
, Issue.12
, pp. 1776-1784
-
-
Kalluri, R.1
Neilson, E.G.2
-
11
-
-
65649120776
-
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: A prospective analysis
-
Arrieta O, Saavedra-Perez D, Kuri R, et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis. BMC Cancer. 2009;9:119.
-
(2009)
BMC Cancer.
, vol.9
, pp. 119
-
-
Arrieta, O.1
Saavedra-Perez, D.2
Kuri, R.3
-
12
-
-
33749366427
-
Primary glioblastomas express mesenchymal stem-like properties
-
Tso CL, Shintaku P, Chen J, et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006;4(9):607-619.
-
(2006)
Mol Cancer Res.
, vol.4
, Issue.9
, pp. 607-619
-
-
Tso, C.L.1
Shintaku, P.2
Chen, J.3
-
13
-
-
4644313275
-
Gene expression profiling of gliomas strongly predicts survival
-
Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004;64(18): 6503-6510.
-
(2004)
Cancer Res.
, vol.64
, Issue.18
, pp. 6503-6510
-
-
Freije, W.A.1
Castro-Vargas, F.E.2
Fang, Z.3
-
14
-
-
33644873765
-
TWIST is expressed in human gliomas and promotes invasion
-
Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion. Neoplasia. 2005;7(9):824-837.
-
(2005)
Neoplasia.
, vol.7
, Issue.9
, pp. 824-837
-
-
Elias, M.C.1
Tozer, K.R.2
Silber, J.R.3
-
15
-
-
84997941720
-
An overview of the c-MET signaling pathway
-
Organ SL, Tsao MS. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3(Suppl 1):S7-S19.
-
(2011)
Ther Adv Med Oncol.
, vol.3
, pp. S7-S19
-
-
Organ, S.L.1
Tsao, M.S.2
-
16
-
-
0024427178
-
Molecular cloning and expression of human hepatocyte growth factor
-
Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342(6248):440-443.
-
(1989)
Nature.
, vol.342
, Issue.6248
, pp. 440-443
-
-
Nakamura, T.1
Nishizawa, T.2
Hagiya, M.3
-
17
-
-
51049117095
-
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of MET
-
Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P. A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of MET. J Biol Chem. 2008;283(30):21267-21277.
-
(2008)
J Biol Chem.
, vol.283
, Issue.30
, pp. 21267-21277
-
-
Basilico, C.1
Arnesano, A.2
Galluzzo, M.3
Comoglio, P.M.4
Michieli, P.5
-
18
-
-
27644543354
-
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
-
Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol. 2005;7(4):436-451.
-
(2005)
Neuro Oncol.
, vol.7
, Issue.4
, pp. 436-451
-
-
Abounader, R.1
Laterra, J.2
-
19
-
-
84864863728
-
MET signaling regulates glioblastoma stem cells
-
Joo KM, Jin J, Kim E, et al. MET signaling regulates glioblastoma stem cells. Cancer Res. 2012;72(15):3828-3838.
-
(2012)
Cancer Res.
, vol.72
, Issue.15
, pp. 3828-3838
-
-
Joo, K.M.1
Jin, J.2
Kim, E.3
-
20
-
-
84865712690
-
The MET oncogene is a functional marker of a glioblastoma stem cell subtype
-
De Bacco F, Casanova E, Medico E, et al. The MET oncogene is a functional marker of a glioblastoma stem cell subtype. Cancer Res. 2012;72(17):4537-4550.
-
(2012)
Cancer Res.
, vol.72
, Issue.17
, pp. 4537-4550
-
-
De Bacco, F.1
Casanova, E.2
Medico, E.3
-
21
-
-
84878540077
-
The MET oncogene in glioblastoma stem cells: Implications as a diagnostic marker and a therapeutic target
-
Boccaccio C, Comoglio PM. The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target. Cancer Res. 2013;73(11):3193-3199.
-
(2013)
Cancer Res.
, vol.73
, Issue.11
, pp. 3193-3199
-
-
Boccaccio, C.1
Comoglio, P.M.2
-
22
-
-
0344845003
-
Epithelial-mesenchymal transitions in development and pathologies
-
Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15(6):740-746.
-
(2003)
Curr Opin Cell Biol.
, vol.15
, Issue.6
, pp. 740-746
-
-
Thiery, J.P.1
-
23
-
-
0037326619
-
Snail precedes Slug in the genetic cascade required for the specification and migration of the Xenopus neural crest
-
Aybar MJ, Nieto MA, Mayor R. Snail precedes Slug in the genetic cascade required for the specification and migration of the Xenopus neural crest. Development. 2003;130(3):483-494.
-
(2003)
Development.
, vol.130
, Issue.3
, pp. 483-494
-
-
Aybar, M.J.1
Nieto, M.A.2
Mayor, R.3
-
25
-
-
0037472881
-
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells
-
Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348(5):403-413.
-
(2003)
N Engl J Med.
, vol.348
, Issue.5
, pp. 403-413
-
-
Yanez-Mo, M.1
Lara-Pezzi, E.2
Selgas, R.3
-
26
-
-
0037406810
-
Response of lens epithelial cells to injury: Role of lumican in epithelial-mesenchymal transition
-
Saika S, Miyamoto T, Tanaka S, et al. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2003;44(5):2094-2102.
-
(2003)
Invest Ophthalmol Vis Sci.
, vol.44
, Issue.5
, pp. 2094-2102
-
-
Saika, S.1
Miyamoto, T.2
Tanaka, S.3
-
27
-
-
0036595629
-
Epithelial-mesenchymal transitions in tumour progression
-
Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442-454.
-
(2002)
Nat Rev Cancer.
, vol.2
, Issue.6
, pp. 442-454
-
-
Thiery, J.P.1
-
28
-
-
0038745381
-
The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis
-
Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003;63(12):3386-3394.
-
(2003)
Cancer Res.
, vol.63
, Issue.12
, pp. 3386-3394
-
-
Xue, C.1
Plieth, D.2
Venkov, C.3
Xu, C.4
Neilson, E.G.5
-
29
-
-
33749344520
-
Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
-
Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006;12(18):5369-5376.
-
(2006)
Clin Cancer Res.
, vol.12
, Issue.18
, pp. 5369-5376
-
-
Lee, T.K.1
Poon, R.T.2
Yuen, A.P.3
-
30
-
-
36348939863
-
Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells
-
Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A, Kikkawa F. Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol. 2007;107(3):500-504.
-
(2007)
Gynecol Oncol.
, vol.107
, Issue.3
, pp. 500-504
-
-
Tsukamoto, H.1
Shibata, K.2
Kajiyama, H.3
Terauchi, M.4
Nawa, A.5
Kikkawa, F.6
-
31
-
-
35148825636
-
Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
-
Kajiyama H, Shibata K, Terauchi M, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol. 2007;31(2):277-283.
-
(2007)
Int J Oncol.
, vol.31
, Issue.2
, pp. 277-283
-
-
Kajiyama, H.1
Shibata, K.2
Terauchi, M.3
-
32
-
-
70349859809
-
Snail and Slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells
-
Kurrey NK, Jalgaonkar SP, Joglekar AV, et al. Snail and Slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells. 2009;27(9):2059-2068.
-
(2009)
Stem Cells.
, vol.27
, Issue.9
, pp. 2059-2068
-
-
Kurrey, N.K.1
Jalgaonkar, S.P.2
Joglekar, A.V.3
-
33
-
-
79954627096
-
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells
-
Rosano L, Cianfrocca R, Spinella F, et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res. 2011;17(8):2350-2360.
-
(2011)
Clin Cancer Res.
, vol.17
, Issue.8
, pp. 2350-2360
-
-
Rosano, L.1
Cianfrocca, R.2
Spinella, F.3
-
34
-
-
84879171839
-
SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance
-
Lim S, Becker A, Zimmer A, Lu J, Buettner R, Kirfel J. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PloS One. 2013;8(6):e66558.
-
(2013)
PloS One.
, vol.8
, Issue.6
-
-
Lim, S.1
Becker, A.2
Zimmer, A.3
Lu, J.4
Buettner, R.5
Kirfel, J.6
-
35
-
-
79959872399
-
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib
-
Suda K, Tomizawa K, Fujii M, et al. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol. 2011;6(7):1152-1161.
-
(2011)
J Thorac Oncol.
, vol.6
, Issue.7
, pp. 1152-1161
-
-
Suda, K.1
Tomizawa, K.2
Fujii, M.3
-
36
-
-
40049084003
-
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance
-
Krysan K, Lee JM, Dohadwala M, et al. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol. 2008;3(2):107-110.
-
(2008)
J Thorac Oncol.
, vol.3
, Issue.2
, pp. 107-110
-
-
Krysan, K.1
Lee, J.M.2
Dohadwala, M.3
-
37
-
-
66249109653
-
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics
-
Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 2009;69(10):4116-4124.
-
(2009)
Cancer Res.
, vol.69
, Issue.10
, pp. 4116-4124
-
-
Hennessy, B.T.1
Gonzalez-Angulo, A.M.2
Stemke-Hale, K.3
-
38
-
-
34648821257
-
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
-
Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 2007;7(10):791-799.
-
(2007)
Nat Rev Cancer.
, vol.7
, Issue.10
, pp. 791-799
-
-
Stingl, J.1
Caldas, C.2
-
39
-
-
34548569038
-
Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity
-
Liao MJ, Zhang CC, Zhou B, et al. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res. 2007;67(17):8131-8138.
-
(2007)
Cancer Res.
, vol.67
, Issue.17
, pp. 8131-8138
-
-
Liao, M.J.1
Zhang, C.C.2
Zhou, B.3
-
40
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4): 704-715.
-
(2008)
Cell.
, vol.133
, Issue.4
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
-
41
-
-
51449085561
-
Generation of breast cancer stem cells through epithelial-mesenchymal transition
-
Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS One. 2008;3(8):e2888.
-
(2008)
PloS One.
, vol.3
, Issue.8
-
-
Morel, A.P.1
Lievre, M.2
Thomas, C.3
Hinkal, G.4
Ansieau, S.5
Puisieux, A.6
-
42
-
-
0043172396
-
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis
-
Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol. 2003;4(8):657-665.
-
(2003)
Nat Rev Mol Cell Biol.
, vol.4
, Issue.8
, pp. 657-665
-
-
Grunert, S.1
Jechlinger, M.2
Beug, H.3
-
43
-
-
0242720727
-
Expression profiling of epithelial plasticity in tumor progression
-
Jechlinger M, Grunert S, Tamir IH, et al. Expression profiling of epithelial plasticity in tumor progression. Oncogene. 2003;22(46):7155-7169.
-
(2003)
Oncogene.
, vol.22
, Issue.46
, pp. 7155-7169
-
-
Jechlinger, M.1
Grunert, S.2
Tamir, I.H.3
-
44
-
-
44449144396
-
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
-
Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6): 818-829.
-
(2008)
Dev Cell.
, vol.14
, Issue.6
, pp. 818-829
-
-
Yang, J.1
Weinberg, R.A.2
-
45
-
-
34447272058
-
Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment
-
Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 2007;101(4):816-829.
-
(2007)
J Cell Biochem.
, vol.101
, Issue.4
, pp. 816-829
-
-
Tse, J.C.1
Kalluri, R.2
-
46
-
-
0034030142
-
TGF-beta signaling by Smad proteins
-
Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev. 2000;11(1-2):15-22.
-
(2000)
Cytokine Growth Factor Rev.
, vol.11
, Issue.1-2
, pp. 15-22
-
-
Miyazono, K.1
-
47
-
-
0033788062
-
TGF-beta/SMAD signaling and its involvement in tumor progression
-
Miyazono K. TGF-beta/SMAD signaling and its involvement in tumor progression. Biol Pharm Bull. 2000;23(10):1125-1130.
-
(2000)
Biol Pharm Bull.
, vol.23
, Issue.10
, pp. 1125-1130
-
-
Miyazono, K.1
-
48
-
-
0035861541
-
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity
-
Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem. 2001;276(50):46707-46713.
-
(2001)
J Biol Chem.
, vol.276
, Issue.50
, pp. 46707-46713
-
-
Bhowmick, N.A.1
Zent, R.2
Ghiassi, M.3
McDonnell, M.4
Moses, H.L.5
-
49
-
-
0035185853
-
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
-
Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12(1):27-36.
-
(2001)
Mol Biol Cell.
, vol.12
, Issue.1
, pp. 27-36
-
-
Bhowmick, N.A.1
Ghiassi, M.2
Bakin, A.3
-
50
-
-
0035991607
-
Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT
-
Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int. 2002;26(5): 463-476.
-
(2002)
Cell Biol Int.
, vol.26
, Issue.5
, pp. 463-476
-
-
Kim, K.1
Lu, Z.2
Hay, E.D.3
-
51
-
-
58149316623
-
Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3
-
Medici D, Hay ED, Olsen BR. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell. 2008;19(11):4875-4887.
-
(2008)
Mol Biol Cell.
, vol.19
, Issue.11
, pp. 4875-4887
-
-
Medici, D.1
Hay, E.D.2
Olsen, B.R.3
-
52
-
-
29144485712
-
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions
-
Vandewalle C, Comijn J, De Craene B, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005;33(20):6566-6578.
-
(2005)
Nucleic Acids Res.
, vol.33
, Issue.20
, pp. 6566-6578
-
-
Vandewalle, C.1
Comijn, J.2
De Craene, B.3
-
53
-
-
0034964418
-
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
-
Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7(6):1267-1278.
-
(2001)
Mol Cell.
, vol.7
, Issue.6
, pp. 1267-1278
-
-
Comijn, J.1
Berx, G.2
Vermassen, P.3
-
54
-
-
45849087087
-
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
-
Ansieau S, Bastid J, Doreau A, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14(1):79-89.
-
(2008)
Cancer Cell.
, vol.14
, Issue.1
, pp. 79-89
-
-
Ansieau, S.1
Bastid, J.2
Doreau, A.3
-
55
-
-
67650045932
-
A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis
-
Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol. 2009;29(13):3722-3737.
-
(2009)
Mol Cell Biol.
, vol.29
, Issue.13
, pp. 3722-3737
-
-
Smit, M.A.1
Geiger, T.R.2
Song, J.Y.3
Gitelman, I.4
Peeper, D.S.5
-
56
-
-
84863349461
-
IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures
-
Xie G, Yao Q, Liu Y, et al. IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int J Oncol. 2012;40(4):1171-1179.
-
(2012)
Int J Oncol.
, vol.40
, Issue.4
, pp. 1171-1179
-
-
Xie, G.1
Yao, Q.2
Liu, Y.3
-
57
-
-
84055207487
-
IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway
-
Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011;9(12):1658-1667.
-
(2011)
Mol Cancer Res.
, vol.9
, Issue.12
, pp. 1658-1667
-
-
Yadav, A.1
Kumar, B.2
Datta, J.3
Teknos, T.N.4
Kumar, P.5
-
58
-
-
79955780958
-
IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2
-
Su YW, Xie TX, Sano D, Myers JN. IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PloS One. 2011;6(4):e19412.
-
(2011)
PloS One.
, vol.6
, Issue.4
-
-
Su, Y.W.1
Xie, T.X.2
Sano, D.3
Myers, J.N.4
-
59
-
-
84879407793
-
STAT3 silencing inhibits glioma single cell infiltration and tumor growth
-
Priester M, Copanaki E, Vafaizadeh V, et al. STAT3 silencing inhibits glioma single cell infiltration and tumor growth. Neuro Oncol. 2013;15(7):840-852.
-
(2013)
Neuro Oncol.
, vol.15
, Issue.7
, pp. 840-852
-
-
Priester, M.1
Copanaki, E.2
Vafaizadeh, V.3
-
60
-
-
84878439525
-
Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein
-
Zarkoob H, Taube JH, Singh SK, Mani SA, Kohandel M. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein. PloS One. 2013;8(5):e64169.
-
(2013)
PloS One.
, vol.8
, Issue.5
-
-
Zarkoob, H.1
Taube, J.H.2
Singh, S.K.3
Mani, S.A.4
Kohandel, M.5
-
61
-
-
47949122097
-
Differential expression of E-cadherin gene in human neuroepithelial tumors
-
Motta FJ, Valera ET, Lucio-Eterovic AK, et al. Differential expression of E-cadherin gene in human neuroepithelial tumors. Genet Mol Res. 2008;7(2):295-304.
-
(2008)
Genet Mol Res.
, vol.7
, Issue.2
, pp. 295-304
-
-
Motta, F.J.1
Valera, E.T.2
Lucio-Eterovic, A.K.3
-
62
-
-
79955559699
-
SNAI1 is involved in the proliferation and migration of glioblastoma cells
-
Han SP, Kim JH, Han ME, et al. SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol Neurobiol. 2011;31(3):489-496.
-
(2011)
Cell Mol Neurobiol.
, vol.31
, Issue.3
, pp. 489-496
-
-
Han, S.P.1
Kim, J.H.2
Han, M.E.3
-
63
-
-
77950461380
-
Identification of the role of Smad interacting protein 1 (SIP1) in glioma
-
Xia M, Hu M, Wang J, et al. Identification of the role of Smad interacting protein 1 (SIP1) in glioma. J Neurooncol. 2010;97(2):225-232.
-
(2010)
J Neurooncol.
, vol.97
, Issue.2
, pp. 225-232
-
-
Xia, M.1
Hu, M.2
Wang, J.3
-
64
-
-
33745489036
-
Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors
-
Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24(4): 1030-1041.
-
(2006)
Stem Cells.
, vol.24
, Issue.4
, pp. 1030-1041
-
-
Honczarenko, M.1
Le, Y.2
Swierkowski, M.3
Ghiran, I.4
Glodek, A.M.5
Silberstein, L.E.6
-
65
-
-
84888069751
-
The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells
-
Zhu Y, Yang P, Wang Q, et al. The effect of CXCR4 silencing on epithelial-mesenchymal transition related genes in glioma U87 cells. Anat Rec. 2013;296(12):1850-1856.
-
(2013)
Anat Rec.
, vol.296
, Issue.12
, pp. 1850-1856
-
-
Zhu, Y.1
Yang, P.2
Wang, Q.3
-
66
-
-
44449151030
-
Drug development of MET inhibitors: Targeting oncogene addiction and expedience
-
Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov. 2008;7(6):504-516.
-
(2008)
Nat Rev Drug Discov.
, vol.7
, Issue.6
, pp. 504-516
-
-
Comoglio, P.M.1
Giordano, S.2
Trusolino, L.3
-
67
-
-
0036551486
-
Scatter-factor and semaphorin receptors: Cell signalling for invasive growth
-
Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat RevCancer. 2002;2(4):289-300.
-
(2002)
Nat RevCancer.
, vol.2
, Issue.4
, pp. 289-300
-
-
Trusolino, L.1
Comoglio, P.M.2
-
68
-
-
0023661693
-
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
-
Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987;327(6119): 239-242.
-
(1987)
Nature.
, vol.327
, Issue.6119
, pp. 239-242
-
-
Stoker, M.1
Gherardi, E.2
Perryman, M.3
Gray, J.4
-
69
-
-
0028301299
-
Autophosphorylation modulates the kinase activity and oncogenic potential of the MET receptor tyrosine kinase
-
Rodrigues GA, Park M. Autophosphorylation modulates the kinase activity and oncogenic potential of the MET receptor tyrosine kinase. Oncogene. 1994;9(7):2019-2027.
-
(1994)
Oncogene.
, vol.9
, Issue.7
, pp. 2019-2027
-
-
Rodrigues, G.A.1
Park, M.2
-
70
-
-
0028351702
-
A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
-
Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994;77(2):261-271.
-
(1994)
Cell.
, vol.77
, Issue.2
, pp. 261-271
-
-
Ponzetto, C.1
Bardelli, A.2
Zhen, Z.3
-
71
-
-
17544371922
-
Pathways downstream of Shc and Grb2 are required for cell transformation by the Tpr-MET oncoprotein
-
Fixman ED, Fournier TM, Kamikura DM, Naujokas MA, Park M. Pathways downstream of Shc and Grb2 are required for cell transformation by the Tpr-MET oncoprotein. J Biol Chem. 1996;271(22):13116-13122.
-
(1996)
J Biol Chem.
, vol.271
, Issue.22
, pp. 13116-13122
-
-
Fixman, E.D.1
Fournier, T.M.2
Kamikura, D.M.3
Naujokas, M.A.4
Park, M.5
-
72
-
-
19444363140
-
The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-MET directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading
-
Koch A, Mancini A, El Bounkari O, Tamura T. The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-MET directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene. 2005;24(21):3436-3447.
-
(2005)
Oncogene.
, vol.24
, Issue.21
, pp. 3436-3447
-
-
Koch, A.1
Mancini, A.2
El Bounkari, O.3
Tamura, T.4
-
73
-
-
0032518375
-
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
-
Boccaccio C, Ando M, Tamagnone L, et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature. 1998;391(6664):285-288.
-
(1998)
Nature.
, vol.391
, Issue.6664
, pp. 285-288
-
-
Boccaccio, C.1
Ando, M.2
Tamagnone, L.3
-
74
-
-
79960000828
-
Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer
-
Organ SL, Tong J, Taylor P, et al. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer. J Proteome Res. 2011;10(7):3200-3211.
-
(2011)
J Proteome Res.
, vol.10
, Issue.7
, pp. 3200-3211
-
-
Organ, S.L.1
Tong, J.2
Taylor, P.3
-
75
-
-
77952017101
-
Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks
-
Hammond DE, Hyde R, Kratchmarova I, Beynon RJ, Blagoev B, Clague MJ. Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks. J Proteome Res. 2010;9(5):2734-2742.
-
(2010)
J Proteome Res.
, vol.9
, Issue.5
, pp. 2734-2742
-
-
Hammond, D.E.1
Hyde, R.2
Kratchmarova, I.3
Beynon, R.J.4
Blagoev, B.5
Clague, M.J.6
-
76
-
-
33746504571
-
Invasive growth: A MET-driven genetic programme for cancer and stem cells
-
Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer. 2006;6(8): 637-645.
-
(2006)
Nat Rev Cancer.
, vol.6
, Issue.8
, pp. 637-645
-
-
Boccaccio, C.1
Comoglio, P.M.2
-
77
-
-
0025824738
-
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
-
Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991;67(5):901-908.
-
(1991)
Cell.
, vol.67
, Issue.5
, pp. 901-908
-
-
Montesano, R.1
Matsumoto, K.2
Nakamura, T.3
Orci, L.4
-
78
-
-
0029869298
-
Co-expression of the HGF/SF and c-MET genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis
-
Andermarcher E, Surani MA, Gherardi E. Co-expression of the HGF/SF and c-MET genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev Genet. 1996;18(3):254-266.
-
(1996)
Dev Genet.
, vol.18
, Issue.3
, pp. 254-266
-
-
Andermarcher, E.1
Surani, M.A.2
Gherardi, E.3
-
79
-
-
0032959159
-
Hepatocyte growth factor expression in the developing myocardium: Evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression
-
Song W, Majka SM, McGuire PG. Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression. Dev Dyn. 1999;214(1):92-100.
-
(1999)
Dev Dyn.
, vol.214
, Issue.1
, pp. 92-100
-
-
Song, W.1
Majka, S.M.2
McGuire, P.G.3
-
80
-
-
0033362351
-
Hepatocyte growth factor, a versatile signal for developing neurons
-
Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci. 1999;2(3):213-217.
-
(1999)
Nat Neurosci.
, vol.2
, Issue.3
, pp. 213-217
-
-
Maina, F.1
Klein, R.2
-
81
-
-
84896720813
-
Targeting epithelial-to-mesenchymal transition with MET inhibitors reverts chemoresistance in small cell lung cancer
-
Canadas I, Rojo F, Taus A, et al. Targeting epithelial-to-mesenchymal transition with MET inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res. 2014;20(4):938-950.
-
(2014)
Clin Cancer Res.
, vol.20
, Issue.4
, pp. 938-950
-
-
Canadas, I.1
Rojo, F.2
Taus, A.3
-
82
-
-
78751523982
-
Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma
-
Nagai T, Arao T, Furuta K, et al. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther. 2011;10(1):169-177.
-
(2011)
Mol Cancer Ther.
, vol.10
, Issue.1
, pp. 169-177
-
-
Nagai, T.1
Arao, T.2
Furuta, K.3
-
83
-
-
84863754907
-
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
-
Lu KV, Chang JP, Parachoniak CA, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012;22(1):21-35.
-
(2012)
Cancer Cell.
, vol.22
, Issue.1
, pp. 21-35
-
-
Lu, K.V.1
Chang, J.P.2
Parachoniak, C.A.3
-
84
-
-
0036896226
-
Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion
-
Lorenzato A, Olivero M, Patane S, et al. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 2002;62(23):7025-7030.
-
(2002)
Cancer Res.
, vol.62
, Issue.23
, pp. 7025-7030
-
-
Lorenzato, A.1
Olivero, M.2
Patane, S.3
-
85
-
-
0034673699
-
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
-
Di Renzo MF, Olivero M, Martone T, et al. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene. 2000;19(12):1547-1555.
-
(2000)
Oncogene.
, vol.19
, Issue.12
, pp. 1547-1555
-
-
Di Renzo, M.F.1
Olivero, M.2
Martone, T.3
-
86
-
-
0028276786
-
Invasiveness and metastasis of NIH 3T3 cells induced by MET-hepatocyte growth factor/scatter factor autocrine stimulation
-
Rong S, Segal S, Anver M, Resau JH, Vande Woude GF. Invasiveness and metastasis of NIH 3T3 cells induced by MET-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A. 1994;91(11):4731-4735.
-
(1994)
Proc Natl Acad Sci U S A.
, vol.91
, Issue.11
, pp. 4731-4735
-
-
Rong, S.1
Segal, S.2
Anver, M.3
Resau, J.H.4
Vande Woude, G.F.5
-
87
-
-
0030030065
-
Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma
-
Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ. 1996;7(2):263-270.
-
(1996)
Cell Growth Differ.
, vol.7
, Issue.2
, pp. 263-270
-
-
Rahimi, N.1
Tremblay, E.2
McAdam, L.3
Park, M.4
Schwall, R.5
Elliott, B.6
-
88
-
-
72949083968
-
Co-overexpression of MET and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells
-
Navab R, Liu J, Seiden-Long I, et al. Co-overexpression of MET and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells. Neoplasia. 2009;11(12):1292-1300.
-
(2009)
Neoplasia.
, vol.11
, Issue.12
, pp. 1292-1300
-
-
Navab, R.1
Liu, J.2
Seiden-Long, I.3
-
89
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007;316(5827):1039-1043.
-
(2007)
Science.
, vol.316
, Issue.5827
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
-
90
-
-
0030690583
-
MET and hepatocyte growth factor/scatter factor expression in human gliomas
-
Koochekpour S, Jeffers M, Rulong S, et al. MET and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 1997;57(23):5391-5398.
-
(1997)
Cancer Res.
, vol.57
, Issue.23
, pp. 5391-5398
-
-
Koochekpour, S.1
Jeffers, M.2
Rulong, S.3
-
91
-
-
58949099258
-
Prognostic significance of c-MET expression in glioblastomas
-
Kong DS, Song SY, Kim DH, et al. Prognostic significance of c-MET expression in glioblastomas. Cancer. 2009;115(1):140-148.
-
(2009)
Cancer.
, vol.115
, Issue.1
, pp. 140-148
-
-
Kong, D.S.1
Song, S.Y.2
Kim, D.H.3
-
92
-
-
78650179903
-
c-MET expression is associated with time to recurrence in patients with glioblastoma multiforme
-
Liu W, Fu Y, Xu S, et al. c-MET expression is associated with time to recurrence in patients with glioblastoma multiforme. J Clin Neurosci. 2011;18(1):119-121.
-
(2011)
J Clin Neurosci.
, vol.18
, Issue.1
, pp. 119-121
-
-
Liu, W.1
Fu, Y.2
Xu, S.3
-
93
-
-
0035089315
-
Signaling pathways in the induction of c-MET receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma
-
Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J. Signaling pathways in the induction of c-MET receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J Neurochem. 2001;76(5):1497-1508.
-
(2001)
J Neurochem.
, vol.76
, Issue.5
, pp. 1497-1508
-
-
Abounader, R.1
Ranganathan, S.2
Kim, B.Y.3
Nichols, C.4
Laterra, J.5
-
94
-
-
79959971880
-
c-MET signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
-
Li Y, Li A, Glas M, et al. c-MET signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A. 2011;108(24):9951-9956.
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, Issue.24
, pp. 9951-9956
-
-
Li, Y.1
Li, A.2
Glas, M.3
-
95
-
-
84875723571
-
Wnt/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells
-
Kim KH, Seol HJ, Kim EH, et al. Wnt/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol. 2013;15(2):161-171.
-
(2013)
Neuro Oncol.
, vol.15
, Issue.2
, pp. 161-171
-
-
Kim, K.H.1
Seol, H.J.2
Kim, E.H.3
-
96
-
-
0031583998
-
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
-
Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 1997;420(1):1-6.
-
(1997)
FEBS Lett.
, vol.420
, Issue.1
, pp. 1-6
-
-
Date, K.1
Matsumoto, K.2
Shimura, H.3
Tanaka, M.4
Nakamura, T.5
-
97
-
-
20544463213
-
Mechanisms and significance of bifunctional NK4 in cancer treatment
-
Matsumoto K, Nakamura T. Mechanisms and significance of bifunctional NK4 in cancer treatment. Biochem Biophys Res Commun. 2005;333(2):316-327.
-
(2005)
Biochem Biophys Res Commun.
, vol.333
, Issue.2
, pp. 316-327
-
-
Matsumoto, K.1
Nakamura, T.2
-
98
-
-
3142512610
-
Targeting the tumor and its microenvironment by a dual-function decoy MET receptor
-
Michieli P, Mazzone M, Basilico C, et al. Targeting the tumor and its microenvironment by a dual-function decoy MET receptor. Cancer Cell. 2004;6(1):61-73.
-
(2004)
Cancer Cell.
, vol.6
, Issue.1
, pp. 61-73
-
-
Michieli, P.1
Mazzone, M.2
Basilico, C.3
-
99
-
-
76649131263
-
Biochemical characterization of AMG 102: A neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor
-
Burgess TL, Sun J, Meyer S, et al. Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor. Mol Cancer Ther. 2010;9(2):400-409.
-
(2010)
Mol Cancer Ther.
, vol.9
, Issue.2
, pp. 400-409
-
-
Burgess, T.L.1
Sun, J.2
Meyer, S.3
-
100
-
-
0037173756
-
K252a inhibits the oncogenic properties of MET, the HGF receptor
-
Morotti A, Mila S, Accornero P, Tagliabue E, Ponzetto C. K252a inhibits the oncogenic properties of MET, the HGF receptor. Oncogene. 2002;21(32):4885-4893.
-
(2002)
Oncogene.
, vol.21
, Issue.32
, pp. 4885-4893
-
-
Morotti, A.1
Mila, S.2
Accornero, P.3
Tagliabue, E.4
Ponzetto, C.5
-
101
-
-
10744228765
-
A selective small molecule inhibitor of c-MET kinase inhibits c-MET-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo
-
Christensen JG, Schreck R, Burrows J, et al. A selective small molecule inhibitor of c-MET kinase inhibits c-MET-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res. 2003;63(21):7345-7355.
-
(2003)
Cancer Res.
, vol.63
, Issue.21
, pp. 7345-7355
-
-
Christensen, J.G.1
Schreck, R.2
Burrows, J.3
-
102
-
-
17144462419
-
Potent and selective inhibitors of the MET [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion
-
Wang X, Le P, Liang C, et al. Potent and selective inhibitors of the MET [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther. 2003;2(11):1085-1092.
-
(2003)
Mol Cancer Ther.
, vol.2
, Issue.11
, pp. 1085-1092
-
-
Wang, X.1
Le, P.2
Liang, C.3
-
103
-
-
0141481285
-
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase
-
Sattler M, Pride YB, Ma P, et al. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase. Cancer Res. 2003;63(17):5462-5469.
-
(2003)
Cancer Res.
, vol.63
, Issue.17
, pp. 5462-5469
-
-
Sattler, M.1
Pride, Y.B.2
Ma, P.3
-
104
-
-
13944276728
-
Functional expression and mutations of c-MET and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer
-
Ma PC, Jagadeeswaran R, Jagadeesh S, et al. Functional expression and mutations of c-MET and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res. 2005;65(4):1479-1488.
-
(2005)
Cancer Res.
, vol.65
, Issue.4
, pp. 1479-1488
-
-
Ma, P.C.1
Jagadeeswaran, R.2
Jagadeesh, S.3
-
105
-
-
79952767398
-
Crizotinib, a small-molecule dual inhibitor of the c-MET and ALK receptor tyrosine kinases
-
Rodig SJ, Shapiro GI. Crizotinib, a small-molecule dual inhibitor of the c-MET and ALK receptor tyrosine kinases. Curr Opin Investig Drugs. 2010;11(12):1477-1490.
-
(2010)
Curr Opin Investig Drugs.
, vol.11
, Issue.12
, pp. 1477-1490
-
-
Rodig, S.J.1
Shapiro, G.I.2
-
106
-
-
84890501051
-
Crizotinib, a c-MET inhibitor, prevents metastasis in a metastatic uveal melanoma model
-
Surriga O, Rajasekhar VK, Ambrosini G, Dogan Y, Huang R, Schwartz GK. Crizotinib, a c-MET inhibitor, prevents metastasis in a metastatic uveal melanoma model. Mol Cancer Ther. 2013;12(12):2817-2826.
-
(2013)
Mol Cancer Ther.
, vol.12
, Issue.12
, pp. 2817-2826
-
-
Surriga, O.1
Rajasekhar, V.K.2
Ambrosini, G.3
Dogan, Y.4
Huang, R.5
Schwartz, G.K.6
-
107
-
-
84893431484
-
Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions
-
Dai J, Zhang H, Karatsinides A, et al. Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions. Clin Cancer Res. 2014;20(3):617-630.
-
(2014)
Clin Cancer Res.
, vol.20
, Issue.3
, pp. 617-630
-
-
Dai, J.1
Zhang, H.2
Karatsinides, A.3
-
108
-
-
84877848587
-
Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition
-
Katayama R, Aoyama A, Yamori T, et al. Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition. Cancer Res. 2013;73(10):3087-3096.
-
(2013)
Cancer Res.
, vol.73
, Issue.10
, pp. 3087-3096
-
-
Katayama, R.1
Aoyama, A.2
Yamori, T.3
-
109
-
-
0035912757
-
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
-
Cao B, Su Y, Oskarsson M, et al. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A. 2001;98(13):7443-7448.
-
(2001)
Proc Natl Acad Sci U S A.
, vol.98
, Issue.13
, pp. 7443-7448
-
-
Cao, B.1
Su, Y.2
Oskarsson, M.3
-
110
-
-
33644769210
-
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts
-
Kim KJ, Wang L, Su YC, et al. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res. 2006;12(4):1292-1298.
-
(2006)
Clin Cancer Res.
, vol.12
, Issue.4
, pp. 1292-1298
-
-
Kim, K.J.1
Wang, L.2
Su, Y.C.3
-
111
-
-
32944467848
-
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-MET-dependent human tumors
-
Burgess T, Coxon A, Meyer S, et al. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-MET-dependent human tumors. Cancer Res. 2006;66(3):1721-1729.
-
(2006)
Cancer Res.
, vol.66
, Issue.3
, pp. 1721-1729
-
-
Burgess, T.1
Coxon, A.2
Meyer, S.3
-
112
-
-
33750683969
-
A novel one-armed anti-c-MET antibody inhibits glioblastoma growth in vivo
-
Martens T, Schmidt NO, Eckerich C, et al. A novel one-armed anti-c-MET antibody inhibits glioblastoma growth in vivo. Clin Cancer Res. 2006;12(20 Pt 1):6144-6152.
-
(2006)
Clin Cancer Res.
, vol.12
, Issue.20
, pp. 6144-6152
-
-
Martens, T.1
Schmidt, N.O.2
Eckerich, C.3
-
113
-
-
84855993422
-
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
-
Xie Q, Bradley R, Kang L, et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma. Proc Natl Acad Sci U S A. 2012;109(2):570-575.
-
(2012)
Proc Natl Acad Sci U S A.
, vol.109
, Issue.2
, pp. 570-575
-
-
Xie, Q.1
Bradley, R.2
Kang, L.3
-
114
-
-
77956296140
-
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth
-
Zhang YW, Staal B, Essenburg C, et al. MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth. Cancer Res. 2010;70(17):6880-6890.
-
(2010)
Cancer Res.
, vol.70
, Issue.17
, pp. 6880-6890
-
-
Zhang, Y.W.1
Staal, B.2
Essenburg, C.3
-
115
-
-
84875800035
-
In vivo c-MET pathway inhibition depletes human glioma xenografts of tumor-propagating stem-like cells
-
Rath P, Lal B, Ajala O, et al. In vivo c-MET pathway inhibition depletes human glioma xenografts of tumor-propagating stem-like cells. Transl Oncol. 2013;6(2):104-111.
-
(2013)
Transl Oncol.
, vol.6
, Issue.2
, pp. 104-111
-
-
Rath, P.1
Lal, B.2
Ajala, O.3
-
116
-
-
67651174457
-
EGFRvIII and c-MET pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
-
Lal B, Goodwin CR, Sang Y, et al. EGFRvIII and c-MET pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Mol Cancer Ther. 2009;8(7):1751-1760.
-
(2009)
Mol Cancer Ther.
, vol.8
, Issue.7
, pp. 1751-1760
-
-
Lal, B.1
Goodwin, C.R.2
Sang, Y.3
|